期刊文献+

低蛋白血症对抗结核药物致药物性肝损害的影响 被引量:3

Influence of hypoproteinemia to drug-induced liver injury during chemotherapy of tuberculosis
下载PDF
导出
摘要 目的:探讨不同程度低蛋白血症对结核患者抗结核治疗过程中药物性肝功能损害的影响。方法:对住院治疗合并低蛋白血症的167例初治肺结核患者,根据治疗前血清白蛋白水平(ALB<35 g/L,ALB<30 g/L,ALB<25 g/L)分为轻、中、重三组,为病例组。同期住院治疗的不合并低蛋白血症的初治肺结核患者216例为对照组。结果:对照组出现药物性肝损害率为7.4%,病例组中轻、中、重度低蛋白组出现肝损害率分别为16.3%、35.2%、39.4%,均明显高于对照组。四组之间比较,差异有统计学意义(P<0.05)。四组患者的血清ALB水平与其肝损害率呈负相关(r=-0.973,P=0.027<0.05)。结论:在抗结核的治疗过程中,低蛋白血症使患者药物性肝损害的发生率增高。 Objective To study influence of different hypoproteinemia on drug - induced hepatitis during chemotherapy of tuberculo- sis. Method According to the serum albumin level of prior treatment ALB 〈 35 g/L, ALB 〈 30 g/L, ALB 〈 25 g/L, 167 tuberculous patients with hypopmteinemia,who were hospitalized for initial treatment ,were divided into three subgroups:light, middling and severity. These pa- tients were studied as research group. 216 pulmonary tuberculosis patients without hypoproteinemia,who were also hospitalized during the same period were selected as control group. Results Rate of drug - induced liver injury in control group was 7. 4% ,light was 16.3% ,med- dling was 35.2% ,the severity was 39.4%, showed obviously higher than control group. By statistic analysis, there were significant differences (P 〈 0. 05 ). There were significant negative correlation between the level of ALB and the rate of drug - induced liver injury ( r = - 0. 973, P = 0. 027 〈 0. 05 ). Conclusion In antitubereulosis therapy, the rate of drug - induced liver injury, in hypoproteinemia were more than in control group.
作者 张丽丽 赵勇
出处 《吉林医学》 CAS 2013年第16期3094-3095,共2页 Jilin Medical Journal
关键词 抗结核药物 肝损害 低蛋白血症 Anti - tuberculous drug Liver injury Hypoproteinemia
  • 相关文献

参考文献3

  • 1梁扩寰,李绍白.肝脏病学.药物性肝病[J].人民卫生出版,2006,1(2):793.
  • 2Ohno M,Yamaguchi I,Fukuda T,et al.Slow N-acetyl-transferase 2 genotype affects the incidence of isoniazid and rifam-picin-induced hepatotoxicity[J].Int J Tuberc Lung Dis,2000;4(3):256.
  • 3冯经华,尹风鸣,严振球.营养不良对抗结核药物肝损害的影响[J].临床军医杂志,2007,35(2):239-241. 被引量:7

二级参考文献12

  • 1尹风鸣,冯经华,李小葵,王巍.抗结核药物致重型肝炎9例临床分析[J].华南国防医学杂志,2003,17(6):41-42. 被引量:1
  • 2侯恕.呼吸疾病的营养支持(现代呼吸系疾病系统讲座第十讲)[J].中华结核和呼吸杂志,1996,19(3):133-135. 被引量:49
  • 3Sharms S K,Balamurugan A,Saha P K,et al.Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment[J].Am J Respir Crit Care Med,2002,166(7):916 -919.
  • 4Teleman M D,Chee C B E,Earnest A,et al.Hepatotoxicity of tuberculosis chemotherapy under general programme conditions in Singapore[J].Iht Tuberc Lung Dis,2002,6 (8):699-705.
  • 5American Thoracic Society/Centers For Disease Control and Prevention (ATS/CDC).Executive Committee,Update:Fatal and Severe Liver Injuries Associated With Rifampin and Pyrazinamide for Latent Tuberculosis Infection,and Revisions in American Thoracic Society/CDC Recommendations-United States,2001[J].Am J Respir Crit Care Med,2006,169(7):1319 -1320.
  • 6Nolan C M,Goldberg S V,Buskin S E.Hepatotoxicity associated with isoniazid prevention therapy[J].JAMA,2006,288:1014-1018.
  • 7Ungo J R,Jones D A,shkin D,et al.Antituberculosis drug-induced hepatotoxicity the role of hepatitis C virus and the human immunodeficienc,virus[J].Am J Respir Cril Care Med,2006,165(7):1871-1876.
  • 8Wang W M,Wu P C,Yuen M F,et al.Antituberculosis drug-related liver dysfunction in chronic hepatitis B infection[J].Hepatology,2000,31:201-206.
  • 9谭守勇,李一耕,廖卓雄,陈志成,谭耀驹.环丙沙星联合治疗复治菌阳肺结核近期疗效观察[J].中国防痨杂志,1997,19(3):122-123. 被引量:38
  • 10杨玲,徐卫国.合成代谢激素与COPD的营养学关系[J].国外医学(呼吸系统分册),2001,21(4):190-191. 被引量:11

共引文献6

同被引文献16

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部